Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAP.U
1751
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
| $19.3M | 0.01% |
+1,869,059
| New | +$19.1M |
|
1752
HSBC
HSBC
$357B
| $19.2M | 0.01% |
742,780
+722,659
| +3,592% | +$17.2M |
|
|
BHVN
1753
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $19.2M | 0.01% |
224,000
+127,100
| +131% | +$10.8M |
|
1754
CALL
Idexx Laboratories
IDXX
$43.4B
| $19.2M | 0.01% |
38,400
+6,500
| +20% | +$2.91M |
|
|
PMT
1755
PennyMac Mortgage Investment
PMT
$824M
| $19.2M | 0.01% |
1,089,378
+396,435
| +57% | +$6.72M |
|
1756
CALL
TripAdvisor
TRIP
$1.26B
| $19.2M | 0.01% |
665,500
+176,300
| +36% | +$4.24M |
|
1757
Maximus
MMS
$2.89B
| $19.1M | 0.01% |
261,561
+188,806
| +260% | +$13.4M |
|
1758
PUT
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $19.1M | 0.01% |
175,324
-40,976
| -19% | -$4.37M |
|
1759
CALL
Bausch Health
BHC
$2.43B
| $19.1M | 0.01% |
917,700
+83,100
| +10% | +$1.55M |
|
1760
CALL
Cardinal Health
CAH
$54.7B
| $19.1M | 0.01% |
356,100
-116,900
| -25% | -$6.07M |
|
1761
CALL
Mondelez International
MDLZ
$81.2B
| $19M | 0.01% |
325,600
-386,100
| -54% | -$22.1M |
|
1762
PUT
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.9M
| $19M | ﹤0.01% |
163,928
+100,428
| +158% | +$8.99M |
|
1763
Keros Therapeutics
KROS
$200M
| $19M | ﹤0.01% |
+269,243
| New | +$17M |
|
1764
Ralph Lauren
RL
$23.2B
| $19M | ﹤0.01% |
183,047
-72,550
| -28% | -$6.09M |
|
1765
CALL
Sysco
SYY
$39.7B
| $19M | ﹤0.01% |
255,700
-219,400
| -46% | -$15.1M |
|
|
XIFR
1766
XPLR Infrastructure LP
XIFR
$1.11B
| $18.9M | ﹤0.01% |
282,605
+111,805
| +65% | +$7.21M |
|
1767
CALL
Molson Coors Class B
TAP
$7.97B
| $18.9M | ﹤0.01% |
418,700
+147,300
| +54% | +$6.07M |
|
1768
PUT
Chubb
CB
$133B
| $18.9M | ﹤0.01% |
122,800
-35,000
| -22% | -$4.91M |
|
|
SPWR
1769
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $18.9M | ﹤0.01% |
736,800
+527,400
| +252% | +$10.7M |
|
|
1770
JPMorgan Chase
JPM
$964B
| $18.9M | ﹤0.01% |
148,596
-3,268,822
| -96% | -$365M |
|
1771
Regeneron Pharmaceuticals
REGN
$82.7B
| $18.9M | ﹤0.01% |
39,021
+23,016
| +144% | +$12.4M |
|
|
JOBS
1772
DELISTED
51job Inc
JOBS
| $18.8M | ﹤0.01% |
268,981
+114,131
| +74% | +$8.24M |
|
|
MNDT
1773
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $18.8M | ﹤0.01% |
815,900
+115,500
| +16% | +$1.78M |
|
1774
Kiniksa Pharmaceuticals
KNSA
$5.99B
| $18.8M | ﹤0.01% |
1,064,734
-12,210
| -1% | -$214K |
|
1775
Guidewire Software
GWRE
$14.6B
| $18.8M | ﹤0.01% |
146,107
+120,545
| +472% | +$13.8M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.